Specialty Pharmacy

A look back at the debate around direct and indirect remuneration fees in 2017.

Enzymes that protect the immune system may malfunction and provoke cancer-related mutations.

Rinku Patel, PharmD, RPh, CEO and founder of KloudScript, discusses potential opportunities for specialty pharmacies as technology continues to evolve.

A review of the most popular video interviews on Specialty Pharmacy Times.

Pembrolizumab plus trastuzumab may overcome drug-resistance among patients with advanced HER2+ breast cancer.

Jonathan Ogurchak, PharmD, CSP, vice president of Business Operations at PANTHERx Specialty Pharmacy, discusses which drugs are expected to dominate the market in 2017.

Top news of the day from across the health care landscape.

Paclitaxel plus nintedanib overcomes chemotherapy-resistance in endometrial cancer.

Top news of the week from Specialty Pharmacy Times.

Inhibiting a protein kinase may improve the efficacy of radiation in glioblastoma.

Significant opportunities exist for the development of new drugs for relapsing remitting multiple sclerosis.

If one-quarter of HIV-negative patients took PrEP, a significant amount of new HIV infections could be prevented.

Treatment with hydroxyurea increased hemoglobin F levels for patients with sickle cell anemia.

The FDA issued new draft guidances to expedite the approval of novel targeted drugs.

Nivolumab (Opdivo) showed better tolerability than ipilimumab (Yervoy) in patients with metastatic melanoma.

Pertuzumab (Perjeta) plus trastuzumab and chemotherapy improved invasive disease-free survival in patients with HER2+ breast cancer.

Top news of the day from across the health care landscape.

Priority areas that pharmacists should focus on ahead of USP .

Cabozantinib (Cabometyx) was previously granted priority review as a therapy for advanced renal cell carcinoma.

Bosutinib (Bosulif) was approved by the FDA to treat patients with chronic phase Philadelphia chromosome positive chronic myelogenous leukemia.

Trastuzumab (Herceptin) is indicated to treat HER2+ breast and gastric cancers.

Patients treated with chemotherapy biweekly were 17% less likely to experience breast cancer recurrence over 10 years.

Elvin Montanez, PharmD, chief operations officer at BioPlus Specialty Pharmacy, discusses the importance of a quick turnaround from patient referral to acceptance.

Human Vaccines Project seeks to decode the human immune system to facilitate accelerated development of diagnostics, vaccines and therapies for major global diseases.

Top news of the day from across the health care landscape.

Luxturna (voretigene neparvovec-rzyl) is indicated to treat confirmed biallelic RPE65 mutation-associated retinal dystrophy.

The average profit from cancer drugs administered by 340B hospitals was nearly 50% in 2015.

CAR T cell therapy resulted in a high response rate among previously-treated patients with multiple myeloma.